Nutex Health NUTX Q2 2025 Earnings Transcript

Motley Fool Transcribing, The Motley Fool

Mon, May 4, 2026 astatine 10:51 AM CDT 40 min read

Image source: The Motley Fool.

DATE

Friday, Aug. 15, 2025 astatine 10:30 a.m. ET

CALL PARTICIPANTS

• Chairman & Chief Executive Officer — Thomas T. Vo

• Chief Financial Officer — Jon C. Bates

• President — Warren Hosseinion

• Chief Medical Officer — Michael Chang

• Investor Relations — Vivian Sanders

Full Conference Call Transcript

Thomas T. Vo: Thank you, Vivian, and bully morning, everyone. I americium thrilled to contiguous Nutex Health's preliminary results for the 2nd 4th of 2025, which builds connected the beardown momentum from our archetypal 4th and reflects our continued execution of a patient-first, high-quality attraction model. Our micro infirmary approach, combined with beardown operational ratio and effectual gross rhythm absorption has driven continued robust growth. Let maine archetypal sermon our operational results. And Jon volition update everyone with our advancement connected the audit and interim reappraisal of our financials with our caller auditor. Operationally, Q2 2025 shows beardown show with full diligent visits reaching 45,573, a 10.6% summation from Q2 of 2024.

For the archetypal fractional of 2025, full diligent visits were 93,842, a 15.5% summation from the archetypal fractional of 2024. Total gross accrued to $244 cardinal for the 3 months ended June 30, 2025, arsenic compared to full gross of $76.1 cardinal for the aforesaid play successful 2024, an summation of 220%. Gross nett was $124.8 cardinal oregon 51.1% of full gross for the 3 months ended June 30, 2025, arsenic compared to gross nett of $22.6 cardinal oregon 29.7% of full gross for the aforesaid play of 2024. Adjusted EBITDA attributed to Nutex Health was $73.3 cardinal arsenic compared to adjusted EBITDA attributed to Nutex Health of $6.8 cardinal for the 3 months ended June 30, 2024.

Net currency from operating activities was $78.2 cardinal for the six months ended June 30, 2025, compared to $16.3 cardinal for the aforesaid play successful 2024. As of 6/30/2025, we had $96.7 cardinal of currency successful the bank. The beardown show was a testament to our beardown fundamentals and dedication and collaboration from each of the squad members present astatine Nutex arsenic we strive to fulfill our halfway ngo of providing amended entree to wellness care. One operator of our fiscal occurrence successful summation to beardown measurement maturation and higher diligent acuity is our arbitration strategy nether the No Surprises Act autarkic quality solution process.

Congress enacted the No Surprises Act "NSA" effectual January 1, 2022, to support patients from astonishment aesculapian bills incurred erstwhile they person exigency aesculapian services from out-of-network wellness attraction providers. Providers measure the insurers directly. And if the insurer doesn't wage oregon successful presumption of the supplier underpays for the aesculapian services provided, the NSA creates the autarkic quality solution oregon IDR process for unresolved billing disputes betwixt providers and insurers. The diligent is not progressive successful this process, and outgo is issued straight to the supplier from the insurer. The IDR process safeguards providers by promoting just reimbursement for payers, helping guarantee their continued quality to present care.